• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEURONETICS, INC. NEUROSTAR ADVANCED THERAPY; TRANSCRANIAL MAGNETIC STIMULATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEURONETICS, INC. NEUROSTAR ADVANCED THERAPY; TRANSCRANIAL MAGNETIC STIMULATION Back to Search Results
Model Number NEUROSTAR ADVANCED THERAPY V3.0
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Convulsion/Seizure (4406)
Event Date 10/12/2023
Event Type  Injury  
Event Description
Provider contaced neuronetics to report a patient who had experienced a seizure during their 17th treatment session.
 
Manufacturer Narrative
Neuronetics was contacted by a provider that reported one of their patients had experienced a seizure about 10 minutes into their 17th treatment session.Patient's vitals were monitored at the provider's office and patient's spouse was called following the event.Patient was taken back home by spouse.Provider followed up with the patient the next day following the event who reported that she was "still stiff/hurting" last night but did not have a headache.Patient had requested provider refer her to neurology.The referred neurologist requested that the patient go to the er to faciliate access to an earlier appointment.Er notes that at the time of visit: patient had not continued with tms, has not experienced any more seizures, and expresses that she would like to continue with tms.Per er notes, patient's exam was normal and neurology has cleared the patient to return for tms with seizure precautions in the office.Despite being cleared by neurology to continue with treatment, patient has decided not to conitnue at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEUROSTAR ADVANCED THERAPY
Type of Device
TRANSCRANIAL MAGNETIC STIMULATION
Manufacturer (Section D)
NEURONETICS, INC.
3222 phoenixville pike
malvern PA 19355
Manufacturer (Section G)
NEURONETICS, INC.
3222 phoenixville pike
malvern PA 19355
Manufacturer Contact
anna gorbunov
3222 phoenixville pike
malvern, PA 19355
6106404202
MDR Report Key18525087
MDR Text Key333024879
Report Number3004824012-2024-00002
Device Sequence Number1
Product Code OBP
UDI-Device Identifier00869378000117
UDI-Public00869378000117
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K220127
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 01/17/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/17/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNEUROSTAR ADVANCED THERAPY V3.0
Device Catalogue Number81-02315-000
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/19/2023
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
ALBUTEROL 90 MCG/ACTUATION 2 PUFFS BY MOUTH.; AMITRIPTYLINE 150 MG AT BEDTIME.; METOPROLOL SUCCINATE ER 50 MG DAILY.; VITAMIN B COMPLEX.; VITAMIN D2.
Patient Outcome(s) Other;
Patient Age32 YR
Patient SexFemale
Patient Weight117 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-